Young women's global breast cancer patient database
Breast cancer in young women is much more common in low- and middle-income countries (LMICs) than in high-income countries (HICs).
In fact, breast cancer in young women is considered a “rare disease” in HICs and is difficult to study due to the relatively low number of cases and because most clinical trials exclude younger women from their cohorts.
Even though this disease represents a much larger medical and socioeconomic burden on communities in LMICs, no aggregate clinical and epidemiological data exists to study the characteristics and needs of this rare, but important, subset of patients.